ALDX 5.01 ▼ -1.96% Live Trading Data - Stocknear

Aldeyra Therapeutics Inc.

NASDAQ: ALDX · Real-Time Price · USD
5.01
-0.10 (-1.96%)
At close: Sep 24, 2025, 3:59 PM
5.00
-0.20%
After-hours: Sep 24, 2025, 07:21 PM EDT
-1.96%
Bid 4.99
Market Cap 300.83M
Revenue (ttm) 244.53K
Net Income (ttm) -50.62M
EPS (ttm) -0.85
PE Ratio (ttm) -5.89
Forward PE 33
Analyst Buy
Dividends n/a
Ask 5.3
Volume 542,360
Avg. Volume (20D) 1,047,649
Open 5.15
Previous Close 5.11
Day's Range 4.97 - 5.26
52-Week Range 1.14 - 7.20
Beta 0.79
Ex-Dividend Date n/a

About ALDX

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ALDX
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ALDX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
Aldeyra Therapeutics Inc. is scheduled to release its earnings on Nov 6, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
5 months ago
-73.36%
Aldeyra Therapeutics shares are trading lower afte... Unlock content with Pro Subscription
10 months ago
+11.64%
Aldeyra Therapeutics shares are trading higher after the FDA accepted its resubmitted new drug application for Reproxalap for the treatment of dry eye disease, prompting the company to announce an expansion of its option agreement with AbbVie.